Ou D, Mitchell L A, Domeier M E, Tsang A O, Décarie D, Tingle A J, Nepom G T, Lacroix M, Zrein M
Department of Paediatrics, Faculty of Medicine, Children's Hospital, University of British Columbia, Vancouver, Canada.
Int Immunol. 1996 Oct;8(10):1577-86. doi: 10.1093/intimm/8.10.1577.
The influence of glutamic acid (E)-alanine (A) dimorphism at position 74 of the DR4 beta chain on cytotoxic T cell recognition of an antigenic rubella virus peptide, E1(273-284), was studied using a panel of B cell lines and B cell transfectants expressing different HLA-DRB1 alleles as antigen-presenting cells and targets in 51Cr-release assays. Only B cell lines expressing the DRB10403, DRB10406 or DRB10407 subtypes which shared a residue, E, at position 74 in the DR4 beta chain when sensitized with E1(273-284) elicited strong cytotoxic T lymphocyte responses. However, in direct binding and antibody inhibition assays, it was shown that biotinylated E1(272-285) could bind to DR molecules with residues other than E at position 74, including DRB10401, DRB10404 and DRB11101 expressed on transfectants. E1(272-285) bound with similar affinity to the transfectant with DRB10403, which has E at position 74, as well as the transfectant with DRB10404, which does not. When T-B cell engagement rates were compared in cell conjugate assays, the percentage of T-B conjugates was higher when peptide-pulsed transfectants with DRB10403 were used than with transfectants expressing DRB10404. Hence, the HLA DR beta 1 polymorphism at position 74, while not critical for the binding affinity of E1(272-285) to the HLA molecule, appears to be a primary determinant of restricted recognition and subsequent activation of the peptide-specific T cells.
利用一组B细胞系和表达不同HLA - DRB1等位基因的B细胞转染体作为抗原呈递细胞和51Cr释放试验中的靶细胞,研究了DR4β链第74位谷氨酸(E)-丙氨酸(A)二态性对抗原性风疹病毒肽E1(273 - 284)细胞毒性T细胞识别的影响。在用E1(273 - 284)致敏时,只有表达DRB10403、DRB10406或DRB10407亚型的B细胞系能引发强烈的细胞毒性T淋巴细胞反应,这些亚型在DR4β链的第74位共享一个E残基。然而,在直接结合和抗体抑制试验中,结果显示生物素化的E1(272 - 285)能与第74位残基不是E的DR分子结合,包括转染体上表达的DRB10401、DRB10404和DRB11101。E1(272 - 285)与在第74位有E的DRB10403转染体以及没有E的DRB10404转染体的结合亲和力相似。在细胞结合试验中比较T - B细胞结合率时,使用用DRB10403肽脉冲转染体时的T - B结合物百分比高于使用表达DRB10404转染体时。因此,DRβ1第74位的HLA多态性虽然对E1(272 - 285)与HLA分子的结合亲和力不是关键因素,但似乎是肽特异性T细胞受限识别和后续激活的主要决定因素。